WebAbout GlaxoSmithKline. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, … WebWe are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.
GSK share price GSK
WebMay 31, 2024 · GSK pagherà ad Affinivax 2,1 miliardi di dollari in anticipo e fino a 1,2 miliardi di dollari in potenziali milestone. L'acquisizione arriva dopo che, il mese scorso, GSK ha manifestato l'intenzione di concludere altri affari, dopo l'acquisto di Sierra Oncology per 1,9 miliardi di dollari. WebReturn On Tangible Equity. Current and historical book value per share for GSK (GSK) from 2010 to 2024. Book value per share can be defined as the amount of equity available to shareholders expressed on a per common share basis. GSK book value per share for the three months ending December 31, 2024 was $5.79. Compare GSK With Other Stocks. qld red book
GSK (LSE:GSK) - Stock Price, News & Analysis - Simply Wall St
WebApr 13, 2024 · The market value of equity (E) is also called "Market Cap". As of today, GSK's market capitalization (E) is $77210.094 Mil. As of today, GSK's market … WebMore About Current Valuation All Equity Analysis Current GlaxoSmithKline PLC Current Valuation 90.86 B Most of GlaxoSmithKline PLC's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. qld red and blue lines